Notice2021-20478
Advisory Committee on Immunization Practices (ACIP); Correction Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 22, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: http:/ /www.cdc.gov/vaccines/acip/index.html.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 181 (Wednesday, September 22, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 181 (Wednesday, September 22, 2021)]
[Notices]
[Pages 52684-52685]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-20478]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2021-0089]
Advisory Committee on Immunization Practices (ACIP); Correction
Notice of Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public. Time will be available for
public comment. The meeting will be webcast live via the World Wide
Web; for more information on ACIP please visit the ACIP website: <a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>.
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the
meeting of the Advisory Committee on Immunization Practices (ACIP);
August 30, 2021, 10:00 a.m. to 4:00 p.m., and August 31, 2021, 10:00
a.m. to 4:00 p.m., EDT (times subject to change), in the amended FRN.
The virtual meeting was published in the Federal Register on
Thursday, August 26, 2021, Volume 86, Number 163, pages 47644-47645.
The virtual meeting is being corrected to change the dates and
times, addresses and written public comment and should read as follows:
DATES: The meeting will be held on August 30, 2021, from 10:00 a.m. to
4:00 p.m., EDT (times subject to change). The docket will close on
August 30, 2021. Written comments must be received on or before August
30, 2021.
A notice of this ACIP meeting has also been posted on CDC's ACIP
website at: <a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>. In addition,
CDC has sent notice of this ACIP meeting by email to those who
subscribe to receive email updates about ACIP. The meeting is open to
the public.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0089 by any of the following methods:
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Centers for Disease Control and Prevention, 1600
Clifton Road NE, MS H24-8, Atlanta, Georgia 30329-
[[Page 52685]]
4027, Attn: August 30, 2021 ACIP Meeting.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the <a href="https://www.regulations.gov">https://www.regulations.gov</a> suitability policy will be posted
without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
In accordance with 41 CFR 102-3.150(b), less than 15 calendar days'
notice is being given for this meeting due to the exceptional
circumstances of the COVID-19 pandemic and rapidly evolving COVID-19
vaccine development and regulatory processes. The Secretary of Health
and Human Services has determined that COVID-19 is a Public Health
Emergency.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Immunization and Respiratory Diseases, 1600 Clifton
Road NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367;
Email: <a href="/cdn-cgi/l/email-protection#aeefede7feeecdcacd80c9c1d8"><span class="__cf_email__" data-cfemail="a9e8eae0f9e9cacdca87cec6df">[email protected]</span></a>.
Public Participation
Written Public Comment: The docket will close on August 30, 2021.
Written comments must be received on or before August 30, 2021.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-20478 Filed 9-21-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 22, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.